A comparative study of PD-L1 IHC assays using immune cell scoring and CPS in breast cancer.

Bin Li,Lloye M. Dillon,Jennifer Jones,Keyur Desai,David Gold,Dimple Pandya,Mustimbo Roberts

A comparative study of PD-L1 IHC assays using immune cell scoring and CPS in breast cancer.

2020

Bin Li
Lloye M. Dillon
Jennifer Jones
Keyur Desai
David Gold
Dimple Pandya
Mustimbo Roberts

e15262Background: The clinical benefit of immune checkpoint inhibitors (ICIs) targeting the programmed death-1/programmed death ligand 1 (PD-L1) pathway has previously been demonstrated across a ra...

Keywords:

Oncology
Immunohistochemistry
Breast cancer
Immune system
Internal medicine
Cell
PD-L1
Pathology
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations